1152107-25-9 Usage
General Description
The chemical compound "Cyclopentanepropanoic acid, α-[(forMylhydroxyaMino)Methyl]-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-Methyl-4-pyriMidinyl]hydrazide, (αR)-" is a complex molecule with a long name. It contains a cyclopentanepropanoic acid core with an α-[(forMylhydroxyaMino)Methyl]- group attached to it, as well as a 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-Methyl-4-pyriMidinyl]hydrazide side chain. The compound has a chiral center, denoted by the (αR)- at the end of its name, indicating that it has a specific three-dimensional arrangement of atoms. This complex chemical likely has important pharmacological or biological properties due to its intricate structure.
Check Digit Verification of cas no
The CAS Registry Mumber 1152107-25-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,2,1,0 and 7 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1152107-25:
(9*1)+(8*1)+(7*5)+(6*2)+(5*1)+(4*0)+(3*7)+(2*2)+(1*5)=99
99 % 10 = 9
So 1152107-25-9 is a valid CAS Registry Number.
1152107-25-9Relevant articles and documents
PROCESS FOR PREPARING PEPTIDE DEFORMYLASE INHIBITORS
-
, (2014/09/29)
The present invention relates to processes for making {2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl) hydrazino]-3-oxopropyl}hydroxyformamide compounds of Formula (I), or pharmaceutically acceptable salts thereof and corresponding intermediates thereof, where su
PEPTIDE DEFORMYLASE INHIBITORS
-
Page/Page column 89-90, (2009/06/27)
The present invention is directed to certain {2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3-oxopropyl}hydroxyformamide derivatives, compositions containing them, the use of such compounds in the inhibition of bacterial peptide deformylase (PDF) activity, and in the treatment of bacterial infections. Specifically, the invention is directed to compounds of formula (I), wherein R1, R2 and R3 are defined herein and to pharmaceutically acceptable salts thereof. The compounds of this invention are bacterial peptide deformylase inhibitors and can be useful in the treatment of bacterial infections.
